All Roll Calls
Yes: 189 • No: 0
IndianaSB 262Second Regular Session 124th General Assembly (2026)SenateWALLET
INSPECT program.
Sponsored By: Michael Crider (Republican)
Became Law
health and provider servicesthe housepublic health
Your PRIA Score
Score Hidden
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
5 provisions identified: 0 benefits, 1 costs, 4 mixed.
Doctors must check INSPECT before opioids
Beginning July 1, 2026, a practitioner must check INSPECT or the patient’s integrated health record before prescribing an opioid or benzodiazepine. Exceptions apply for no Internet at the practice (with a waiver), when a patient is completing another practitioner’s prescription while inpatient or in observation, during a database outage (document the attempt), and for hospice patients. For patients under a pain management contract, checking is required no more than once every 90 days. A practitioner who checks in good faith is immune from civil liability, except for gross negligence or intentional misconduct.
Retail pharmacies restrict unknown customers
Beginning July 1, 2026, retail pharmacies may not dispense ephedrine, pseudoephedrine, or a controlled drug to someone the dispenser does not personally know. This rule applies only in retail pharmacy settings. It can limit pickup for people without an existing relationship with that pharmacy.
Faster pharmacy reporting to INSPECT
Beginning July 1, 2026, dispensers must send INSPECT data within 24 hours after dispensing, or by the next business day if closed. Reports must include key fields like patient name, ID number, birth date, NDC, date, quantity, days’ supply, prescriber and dispenser DEA numbers, and whether the prescription was oral or written. Upload through the INSPECT website or another board‑approved electronic method. The law defines what counts as a “dispense” and sets clear carve‑outs: no reporting when a drug is given directly to a patient and no reporting for a practitioner’s 72‑hour or less supply of a Schedule II–V drug. A separate exemption also applies to veterinary dispensings of 72 hours or less.
Who can see INSPECT data
Beginning July 1, 2026, INSPECT data also covers clinical alerts, overdose or poisoning reports, and whether someone is in an opioid treatment program. The board may share data with the state health department and the family and social services office to help active controlled‑substance investigations and to prevent overdoses. Opioid treatment programs must get patient consent under federal rules (42 CFR 2.36 and 2.31) before reporting to INSPECT.
Single secure prescription form option
Beginning July 1, 2026, the pharmacy board may require a single, non‑duplicable prescription form for ephedrine, pseudoephedrine, and other controlled drugs. The rule does not apply to prescriptions filled at hospital pharmacies with a Category II permit or to prescriptions for enrolled patients in certain state‑licensed facilities. The board cannot require multi‑copy forms or different forms for different drugs.
Sponsors & Cosponsors
Sponsor
Michael Crider
Republican • Senate
Cosponsors
Brad Barrett
Republican • House
Cindy Ledbetter
Republican • House
Ed Charbonneau
Republican • Senate
Lori Goss-Reaves
Republican • House
Roll Call Votes
Senate vote • 2/25/2026
Roll Call 287 on SB0262.04.COMH.CON01
Yes: 47 • No: 0 • Other: 2
House vote • 2/23/2026
Roll Call 312 on SB0262.04.COMH
Yes: 94 • No: 0 • Other: 1
Senate vote • 1/28/2026
Roll Call 127 on SB0262.03.ENGS
Yes: 48 • No: 0
Actions Timeline
Public Law 133
3/5/2026SenateSigned by the Governor
3/5/2026SenateSigned by the President Pro Tempore
2/27/2026SenateSigned by the President of the Senate
2/27/2026SenateSigned by the Speaker
2/27/2026HouseSenate concurred with House amendments; Roll Call 287: yeas 47, nays 0
2/25/2026SenateMotion to concur filed
2/24/2026SenateReturned to the Senate with amendments
2/24/2026HouseThird reading: passed; Roll Call 312: yeas 94, nays 0
2/23/2026HouseSecond reading: ordered engrossed
2/19/2026HouseCommittee report: amend do pass, adopted
2/17/2026HouseFirst reading: referred to Committee on Public Health
2/2/2026HouseReferred to the House
1/29/2026SenateThird reading: passed; Roll Call 127: yeas 48, nays 0
1/28/2026SenateCosponsors: Representatives Barrett, Ledbetter
1/28/2026SenateHouse sponsor: Representative Goss-Reaves
1/28/2026SenateAmendment #2 (Crider) prevailed; voice vote
1/26/2026SenateSecond reading: amended, ordered engrossed
1/26/2026SenateSenator Charbonneau added as second author
1/22/2026SenateCommittee report: amend do pass, adopted
1/15/2026SenateAuthored by Senator Crider
1/8/2026SenateFirst reading: referred to Committee on Health and Provider Services
1/8/2026Senate
Bill Text
Engrossed Senate Bill (H)
Enrolled Senate Bill (S)
Introduced Senate Bill (S)
Senate Bill (S)